Literature DB >> 17548214

A molecular and histological characterization of cartilage from patients with Morquio syndrome.

L De Franceschi1, L Roseti, G Desando, A Facchini, B Grigolo.   

Abstract

OBJECTIVE: To investigate the gene expression profile and the histological aspects of articular cartilage of patients affected by Morquio syndrome, a lysosomal storage disease characterized by the accumulation of glycosaminoglycans within the cells which result in abnormal formation and growth of the skeletal system.
METHOD: Articular cartilage samples were obtained from the femoral condyle of two siblings with Morquio syndrome during surgery performed to treat valgus knee. As controls, four biopsy samples of healthy cartilage were obtained from four different male multiorgan donors. A Real-Time Polymerase Chain reaction (RT-PCR) analysis was performed to evaluate the expression of type I and II collagens and aggrecan mRNAs. Histological and immunohistochemical analyses for some matrix proteins were carried out on paraffin embedded sections.
RESULTS: Type I collagen mRNA mean level was higher in the samples of patients with Morquio syndrome compared to controls. Type II collagen and aggrecan mRNAs' mean expression was instead lower. The morphological appearance of the cartilage showed a poorly organized tissue structure with not homogeneously distributed cells that were larger compared to normal chondrocytes due to the presence inside the vacuoles of proteoglycans which were not metabolized. Chondrocytes were negative for collagen II immunostaining while the extracellular matrix was weakly positive. Collagen type I immunostaining was positive at cellular level. Keratan sulfate showed diffuse positivity and chondroitin-6-sulfate was present throughout the cartilaginous thickness.
CONCLUSION: In cartilage of patients with Morquio syndrome, a low expression of collagen type II and a high expression of collagen type I both at protein and molecular levels are evidentiated. This finding could give evidence of the reduction in ankle and knee joint movement observable in these patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548214     DOI: 10.1016/j.joca.2007.04.008

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  11 in total

1.  Guided growth may not be the best option for knee valgus deformity in adolescent patients with Morquio-A.

Authors:  D Colmenares-Bonilla; M Vasconcelos-Martinez; J Guerra-Jasso; L Ocampo-Perez
Journal:  Musculoskelet Surg       Date:  2016-12-07

2.  Altered chondrocyte differentiation and extracellular matrix homeostasis in a zebrafish model for mucolipidosis II.

Authors:  Heather Flanagan-Steet; Christina Sias; Richard Steet
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

3.  Specific entities affecting the craniocervical region: syndromes affecting the craniocervical junction.

Authors:  Arnold H Menezes; Timothy W Vogel
Journal:  Childs Nerv Syst       Date:  2008-03-28       Impact factor: 1.475

4.  Current and emerging treatments and surgical interventions for Morquio A syndrome: a review.

Authors:  Shunji Tomatsu; William G Mackenzie; Mary C Theroux; Robert W Mason; Mihir M Thacker; Thomas H Shaffer; Adriana M Montaño; Daniel Rowan; William Sly; Carlos J Alméciga-Díaz; Luis A Barrera; Yasutsugu Chinen; Eriko Yasuda; Kristen Ruhnke; Yasuyuki Suzuki; Tadao Orii
Journal:  Res Rep Endocr Disord       Date:  2012-12

5.  Therapies of mucopolysaccharidosis IVA (Morquio A syndrome).

Authors:  Shunji Tomatsu; Carlos J Alméciga-Díaz; Hector Barbosa; Adriana M Montaño; Luis A Barrera; Tsutomu Shimada; Eriko Yasuda; William G Mackenzie; Robert W Mason; Yasuyuki Suzuki; Kenji E Orii; Tadao Orii
Journal:  Expert Opin Orphan Drugs       Date:  2013-10-01       Impact factor: 0.694

6.  Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.

Authors:  Melita Dvorak-Ewell; Dan Wendt; Chuck Hague; Terri Christianson; Vish Koppaka; Danielle Crippen; Emil Kakkis; Michel Vellard
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

7.  Natural history of Morquio A patient with tracheal obstruction from birth to death.

Authors:  Caitlin Doherty; Lauren W Averill; Mary Theroux; William G Mackenzie; Christian Pizarro; Robert W Mason; Shunji Tomatsu
Journal:  Mol Genet Metab Rep       Date:  2017-12-22

8.  Plasma Proteomic Analysis in Morquio A Disease.

Authors:  José V Álvarez; Susana B Bravo; María Pilar Chantada-Vázquez; Sofía Barbosa-Gouveia; Cristóbal Colón; Olalla López-Suarez; Shunji Tomatsu; Francisco J Otero-Espinar; María L Couce
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

9.  Orthopedic management of the extremities in patients with Morquio A syndrome.

Authors:  Klane K White; Andrea Jester; C Edward Bache; Paul R Harmatz; Renée Shediac; Mihir M Thacker; William G Mackenzie
Journal:  J Child Orthop       Date:  2014-07-08       Impact factor: 1.548

10.  Modeling Morquio A Syndrome: An Anthropometric Study of Body Characteristics and Stature.

Authors:  Agnieszka Różdżyńska-Świątkowska; Krzysztof Szklanny; Jolanta Marucha; Anna Tylki-Szymańska
Journal:  Diagnostics (Basel)       Date:  2020-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.